MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,000 | +33.3% | 19,000 | +8.6% | 0.00% | – |
| Q3 2019 | $3,000 | – | 17,500 | -97.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 752,800 | +200.6% | 0.00% | – |
| Q3 2018 | $1,000 | -99.9% | 250,400 | -46.4% | 0.00% | -100.0% |
| Q2 2018 | $1,606,000 | -36.9% | 467,464 | -53.5% | 0.08% | -37.5% |
| Q1 2018 | $2,544,000 | – | 1,004,612 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |